Supplements vergleichen

Off-label use mirrors approved dosing (10 mg once daily) under a clinician. A prescription drug; not an approved longevity regimen.

Morning

Orale Tablette (Dapagliflozin)

Off-label longevity use mirrors diabetes dosing (commonly 500–1500 mg/day of extended-release with meals) under a clinician. Not an approved longevity regimen, and unnecessary in well-controlled non-diabetics without a clear rationale.

With meals · with food

Extended-release tablet

• Type 1 diabetes (ketoacidosis risk)
• Severe renal impairment per label / dialysis
• History of recurrent diabetic ketoacidosis

• Diuretics
• Insulin / sulfonylureas

• Severe renal impairment (eGFR < 30)
• Acute metabolic acidosis
• Conditions predisposing to lactic acidosis (severe hypoxia, decompensated heart failure)

• Iodinated contrast
• Alcohol (excessive)